GENOVA, Inc.
Stock Price Chart
2026/10/09 19:27 UpdatedPrice Trend
2026/10/09 19:27 UpdatedPrice & Trading Details
2026/10/09 19:27 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/10/01Dividend History
Updated 2026/10/04| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥30 | 0.0% |
| 2025 | ¥30 | - |
Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥6,513M | ¥8,683M | ¥10,006M | ¥11,566M |
| Gross Profit | ¥4,790M | ¥6,553M | ¥7,378M | ¥6,470M |
| Operating Income | ¥1,734M | ¥2,301M | ¥2,026M | ¥400M |
| Pretax Income | ¥1,719M | ¥2,342M | ¥2,019M | ¥513M |
| Net Income | ¥1,260M | ¥1,727M | ¥1,413M | ¥275M |
| EPS | ¥73.07 | ¥96.50 | ¥79.78 | ¥15.74 |
| Operating Margin | 26.62% | 26.50% | 20.25% | 3.46% |
| Balance Sheet | ||||
| Total Assets | ¥5,415M | ¥8,199M | ¥8,526M | ¥10,256M |
| Total Equity | ¥4,038M | ¥6,037M | ¥6,999M | ¥6,899M |
| Total Liabilities | ¥1,377M | ¥2,162M | ¥1,528M | ¥3,357M |
| Cash | ¥3,861M | ¥5,966M | ¥5,872M | ¥5,317M |
| Interest-bearing Debt | ¥28M | ¥378M | ¥21M | ¥736M |
| Equity Ratio | 74.58% | 73.63% | 82.08% | 67.26% |
| D/E Ratio | 0.01 | 0.06 | 0.00 | 0.11 |
| Cash Flow | ||||
| Operating CF | ¥1,203M | ¥1,822M | ¥1,195M | ¥54M |
| Investing CF | -¥113M | -¥94M | -¥276M | -¥810M |
| Financing CF | ¥1,131M | ¥377M | -¥1,015M | ¥200M |
| Free CF | ¥1,110M | ¥1,765M | ¥1,059M | -¥47M |
| Efficiency | ||||
| ROE | 31.20% | 28.60% | 20.20% | 3.99% |
| ROA | 23.27% | 21.06% | 16.58% | 2.69% |
Latest IR Information
-
Notice on Business Acquisition
Decision to acquire the 'Facts for the body' business of 'From Health to Wellness'. Acquisition price is 51 million yen, revenue for the acquired business is 188 million yen (fiscal year ending April 2026 forecast), settlement in cash. The acquisition...
Read more -
First Quarter Consolidated Financial Results for the Fiscal Year Ending March 2027 (Japanese GAAP) (Consolidated)
Announces the consolidated results for the first quarter of the fiscal year ending March 2027. Revenue increased year over year, with the Medical Platform and Smart Clinic segments contributing to solid performance. The financial position shows asset growth, liabilities growth,...
Read more -
Notice Regarding Executive Officer Personnel Changes
Read more -
Notice of Correction to Partial Amendments to the Consolidated Financial Results for the Fiscal Year Ending March 2026 [Japanese GAAP]
Read more -
Notice of Partial Correction to the Consolidated Financial Results Briefing for the Fiscal Year Ending March 2026 [Japanese Standards] (Revised)
Read more
Latest News (5 items)
Company Information
About
GENOVA, Inc. engages in the medical platform and smart clinic businesses in Japan. It offers Medical Doc, a platform that distributes articles for medical institutions, patient experience articles, treatment videos, and medical-related articles; and online medical treatment and consultation service, which offers medical treatment at home or work for users without going to a hospital. It also provides Smart Clinic, such as NOMOCa-Stand, a smart and simple automatic payment and reception machine; NOMOCa-Regi, a self-pay machine dedicated to the clinic; PNOMOCaAIchat, an AI chat automatic response services; and CLINIC BOT, an AI Chatbot System. The company was incorporated in 2005 and is based in Tokyo, Japan
